Effects of hexestrol on mouse ovarian morphology and ovulation

被引:6
作者
de Oliveira, Joaquim Moraes [1 ]
Simoes, Manuel J. [1 ]
Mora, Oswaldo Alves [1 ]
Simoes, Ricardo Santos [1 ]
Oliveira-Filho, Ricardo M. [1 ]
Oliveira, Patricia B. [1 ]
Baracat, Edmund C. [1 ]
Soares, Jose Maria, Jr. [1 ]
机构
[1] Univ Fed Sao Paulo, Fac Med, Dept Gynecol, BR-04021051 Sao Paulo, Brazil
关键词
hexestrol; ovary; mice; morphology;
D O I
10.1016/j.maturitas.2008.05.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To analyze histological aspects of ovaries as well as the ovulation of adult mice treated with the anabolic agent hexestrol. Methods: Thirty adult mice were divided into three groups of 10 animals each: (GI) the animals received a dose of 3 mg/kg of hexestrol; (GII) the animals were given a dose of 6 mg/kg of hexestrol; (GIII) the animals were injected with distilled water (vehicle). Another 10-animal group (GIV) was included, and these mice were injected with propionate testosterone (1.25 mg) after 5 days from the day of birth. Hexestrol was administered intraperitoneally once a day and the treatment lasted 30 days. The mice were then sacrificed; their ovaries and oviducts were removed, submitted to histological routine and analyzed under light microscopy. Results: In mice treated with hexestrol (6 mg/kg) (Group II), ovaries were smaller than those from the controls but highly vascularized; similar results were obtained in GIV. A great number of follicles in several stages of development were found however, with no corpora lutea - in six animals in GII No corpora lutea were found in GIV. The number of luteal bodies and oocytes in GII was lower than that in GI or GIII. No oocytes were detected in GIV. Finally, the nuclear volume of interstitial cells in GII and GIV was the largest. Conclusion: Our data suggest that the anabolic agent hexestrol in a high dose may decrease ovulation in mice. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 16 条
[1]   Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys [J].
Abbott, David H. ;
Barnett, Deborah K. ;
Levine, Jon E. ;
Padmanabhan, Vasantha ;
Dumesic, Daniel A. ;
Jacoris, Steve ;
Tarantal, Alice F. .
BIOLOGY OF REPRODUCTION, 2008, 79 (01) :154-163
[2]   Developmental origin of polycystic ovary syndrome - a hypothesis [J].
Abbott, DH ;
Dumesic, DA ;
Franks, S .
JOURNAL OF ENDOCRINOLOGY, 2002, 174 (01) :1-5
[3]   Gym users and abuse of prescription drugs [J].
Baker, Julien S. ;
Graham, Michael ;
Davies, Bruce .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2006, 99 (07) :331-332
[4]   Unifying mechanism in the initiation of cancer and other diseases by catechol quinones [J].
Cavalieri, EL ;
Rogan, EG .
SIGNAL TRANSDUCTION AND COMMUNICATION IN CANCER CELLS, 2004, 1028 :247-257
[5]  
Cranwell CD, 1996, J ANIM SCI, V74, P1770
[6]   Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving follicle-stimulating hormone therapy for in vitro fertilization [J].
Dumesic, DA ;
Schramm, RD ;
Bird, IM ;
Peterson, E ;
Paprocki, AM ;
Zhou, R ;
Abbott, DH .
BIOLOGY OF REPRODUCTION, 2003, 69 (04) :1213-1219
[7]  
ERICKSON GF, 1995, PRINCIPLES PRACTICE, P852
[8]   Hepatitis in growth promoter treated cows [J].
Groot, MJ .
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE, 2002, 49 (09) :466-469
[9]  
HOMBURG R, 1990, FERTIL STERIL, V54, P737
[10]  
IGUCHI T, 1981, ENDOCRINOL JAPON, V28, P207